H.W. Sollinger

HUMAN LIVER ALLOGRAFT ACCEPTANCE AND THE “TOLERANCE ASSAY”: IN VITRO ANTI-DONOR T CELL ASSAYS SHOW HYPOREACTIVITY TO DONOR CELLS, BUT UNLIKE DTH, FAIL TO DETECT LINKED SUPPRESSION1

H. Sollinger, W. Burlingham, M. Kalayoglu, 2001, Transplantation.

FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one‐yr multicenter study

H. Sollinger, H. Tedesco-Silva, R. Shapiro, 2009, Clinical transplantation.